New technologies and adaptations of existing technologies can improve platform processes.
Paul Mensah, PhD
Advertisement
Paul Mensah, PhD, is an associate research fellow, at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
Articles by Paul Mensah, PhD
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Advertisement
Latest Updated Articles
Advances in Monoclonal Antibody PurificationMarch 2nd 2010
Advertisement
Advertisement
Trending on BioPharm International
1
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
2
AstraZeneca Acquires Omniose, Adding Bioconjugate Vaccine Platform
3
argenx Agrees to Buy Unnatural Products in Up to $1.15 Billion Deal
4
J&J’s Dual-Antigen Bispecific Regimen Achieves 73% PSA Response in Advanced Prostate Cancer
5